Literature DB >> 33180334

The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction.

Shiyu Li1, Ming Yi1, Bing Dong2, Ximin Tan1, Suxia Luo2, Kongming Wu1,2.   

Abstract

Liquid biopsy is a revolutionary strategy in cancer diagnosis and prognosis prediction, which is used to analyze cancer cells or cancer-derived products through biofluids such as blood, urine and so on. Exosomes play a crucial role in mediating cell communication. A growing number of studies have reported that exosomes are involved in tumorigenesis, tumor growth, metastasis and drug resistance by delivering cargos including nucleic acids and protein. Thus, exosomes, as a new type of liquid biopsy, have the potential to be diagnostic or prognostic biomarkers. Herein, we elaborate on the current methods and introduce novel techniques for exosome isolation and characterization. Moreover, we elucidate the advantages of exosomes compared to other biological components in liquid biopsy and summarize the different exosomal biomarkers in cancer diagnosis and prognosis prediction.
© 2020 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of Union for International Cancer Control.

Entities:  

Keywords:  diagnosis; exosomes; liquid biopsy; prognosis

Year:  2020        PMID: 33180334     DOI: 10.1002/ijc.33386

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

Review 1.  Recent Advances in the Label-Free Characterization of Exosomes for Cancer Liquid Biopsy: From Scattering and Spectroscopy to Nanoindentation and Nanodevices.

Authors:  Riccardo Di Santo; Sabrina Romanò; Alberto Mazzini; Svetlana Jovanović; Giuseppina Nocca; Gaetano Campi; Massimiliano Papi; Marco De Spirito; Flavio Di Giacinto; Gabriele Ciasca
Journal:  Nanomaterials (Basel)       Date:  2021-06-02       Impact factor: 5.076

2.  Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome.

Authors:  Kristina Viktorsson; Petra Hååg; Carl-Henrik Shah; Bo Franzén; Vasiliki Arapi; Karin Holmsten; Per Sandström; Rolf Lewensohn; Anders Ullén
Journal:  Mol Oncol       Date:  2022-08-12       Impact factor: 7.449

Review 3.  Emerging micro-nanotechnologies for extracellular vesicles in immuno-oncology: from target specific isolations to immunomodulation.

Authors:  Nna-Emeka Onukwugha; Yoon-Tae Kang; Sunitha Nagrath
Journal:  Lab Chip       Date:  2022-09-13       Impact factor: 7.517

4.  The role of plasma exosomal lnc-SNAPC5-3:4 in monitoring the efficacy of anlotinib in the treatment of advanced non-small cell lung cancer.

Authors:  Chun Liu; Chenxi Hu; Ting Chen; Yanting Jiang; Xin Zhang; Hongyu Liu; Yuan Wang; Zhi Li; Kaiyuan Hui; Xiaodong Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-07       Impact factor: 4.322

5.  Characterization of extracellular vesicles isolated from different liquid biopsies of uveal melanoma patients.

Authors:  Carmen Luz Pessuti; Deise Fialho Costa; Kleber S Ribeiro; Mohamed Abdouh; Thupten Tsering; Heloisa Nascimento; Alessandra G Commodaro; Allexya Affonso Antunes Marcos; Ana Claudia Torrecilhas; Rubens N Belfort; Rubens Belfort; Julia Valdemarin Burnier
Journal:  J Circ Biomark       Date:  2022-06-27

Review 6.  The Promise of Circulating Tumor DNA in Head and Neck Cancer.

Authors:  Sukhkaran S Aulakh; Dustin A Silverman; Kurtis Young; Steven K Dennis; Andrew C Birkeland
Journal:  Cancers (Basel)       Date:  2022-06-16       Impact factor: 6.575

Review 7.  Cooperation and Interplay between EGFR Signalling and Extracellular Vesicle Biogenesis in Cancer.

Authors:  Laura C Zanetti-Domingues; Scott E Bonner; R Sumanth Iyer; Marisa L Martin-Fernandez; Veronica Huber
Journal:  Cells       Date:  2020-12-08       Impact factor: 6.600

Review 8.  MiRNA-mediated EMT and CSCs in cancer chemoresistance.

Authors:  Bing Dong; Shiyu Li; Shuangli Zhu; Ming Yi; Suxia Luo; Kongming Wu
Journal:  Exp Hematol Oncol       Date:  2021-02-12

Review 9.  EMT-associated microRNAs and their roles in cancer stemness and drug resistance.

Authors:  Guangtao Pan; Yuhan Liu; Luorui Shang; Fangyuan Zhou; Shenglan Yang
Journal:  Cancer Commun (Lond)       Date:  2021-01-27

10.  Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma.

Authors:  Chunyu Huang; Shuiying Tang; Dong Shen; Xiangzhao Li; Li Liang; Yanqing Ding; Bihong Xu
Journal:  Oncol Lett       Date:  2021-01-04       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.